EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic effects of ethmozin on sinus node function in patients with and without sinus node dysfunction


Clinical Cardiology 9(9): 443-448
Electrophysiologic effects of ethmozin on sinus node function in patients with and without sinus node dysfunction
To compare the effects of ethmozin on sinus node (SN) function in the presence (9 patients) and absence (17 patients) of SN dysfunction, sinus cycle length (SCL), maximal corrected sinus recovery time (CSRT), paced cycle length yielding peak SN suppression, and indirect sinoatrial SA conduction time (SACT) were determined before and after intravenous administration of ethmozin in the dose 2 mg/kg. The mean .+-. SD SCL were significantly shortened in patients with normal SN and were not changed in patients with SN dysfunction after ethmozin administration. The mean maximal CSRT was 252 .+-. 72 before and 284 .+-. 86 ms after ethmozin administration in patients with normal SN function (p < 0.05). In patients with SN dysfunction (p < 0.1) the mean maximal CSRT was found to be 1016 .+-. 434 before and 2170 .+-. 1756 ms after ethmozin administration. The mean SACT was 158 .+-. 41 before and 174 .+-. 51 ms after drug administration in patients with normal SN (p < 0.05). Four out of nine patients with SN dysfunction developed second degree SA exit block after ethmozin administration, whereas SACT increased significantly in the remaining group of patients (180 .+-. 35 to 210 .+-. 32 ms; p < 0.05). The PR, PA, AH, and HV intervals significantly lengthened and the valves of QRS and QT were not changed after ethmozin administration in either group. The conclusion is drawn that ethmozin should be administered cautiously to patients with SN dysfunction, particularly to patients with SA exit block, sinus pauses, or secondary pauses (in particular with bradycardia-tachycardia syndrome).

Accession: 005349298

PMID: 3530571

DOI: 10.1002/clc.4960090911

Download PDF Full Text: Electrophysiologic effects of ethmozin on sinus node function in patients with and without sinus node dysfunction



Related references

Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction. Circulation 59(2): 226-235, 1979

Electrophysiological effects of ethmozin on sinus nodal function in patients with and without sinus node dysfunction. European Heart Journal 5(3): 243-246, 1984

Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction. Circulation 54(3): 452-459, 1976

Electrophysiologic evaluation of sinus node function in patients with sinus node dysfunction. Circulation 53(5): 763-776, 1976

Recording of the sinus node potential: comparison with indirect methods of evaluating sinus node function in 10 patients without sinus node dysfunction. Archives des Maladies du Coeur et des Vaisseaux 75(11): 1225-1232, 1982

Electrophysiological effects of glucose-insulin-potassium on sinus node function in patients with and without sinus node dysfunction. Cardiovascular Research 16(10): 566-572, 1982

Electrophysiologic effects of atropine on sinus node and atrium in patients with sinus nodal dysfunction. American Journal of Cardiology 38(7): 848-855, 1976

Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease. American Heart Journal 103(1): 75-79, 1982

The duration of the sinus node depolarization on transvenous sinus node electrograms can identify sinus node dysfunction and can suggest its severity. Pacing and Clinical Electrophysiology 12(11): 1746-1756, 1989

Effects of digoxin on sinus nodal function before and after vagal blockade in patients with sinus nodal dysfunction: a clue to the mechanisms of the action of digitalis on the sinus node. American Journal of Cardiology 43(5): 983-989, 1979